Identification of genes causing human disease provides insight into the molecular pathways involved in normal and abnormal human development. We have recently identified Jagged1 (JAG1) as the disease gene causing Alagille syndrome, a genetic disorder associated with heart, liver and several other anomalies. JAG1 is a ligand in the Notch Signaling pathway, shown in multiple organisms to be involved in cell fate determination. Alagille syndrome is a dominant disorder, with extreme variability in the expression of phenotypic features. Some individuals with JAG1 mutations have only a single clinical feature, rather than the multisystem involvement characteristic of Alagille syndrome. We will study the families of a large cohort of patients with Alagille syndrome both clinically and at the molecular level to determine the complete range of clinical features associated with mutations in JAG1 and to determine the phenotypic effects of a JAG1 mutation; i.e.; what percentage of mutation carriers have clinically significant disease. Given the known clinical variability of features of Alagille syndrome in family members of patients, we have hypothesized that JAG1 mutations will be identified in individuals with isolated heart disease and we have preliminary data to support this hypothesis. We propose to extend this work to study a cohort of patients who have cardiac disease of the types most commonly seen in Alagille syndrome (peripheral pulmonic stenosis, pulmonic stenosis and tetralogy of Fallot) to determine the frequency of JAG1 mutations associated with these cardiac defects. Furthermore, we propose that mutations in other members of the Notch signaling pathway may be associated with cardiac abnormalities. Delta and SMRT are two genes we propose to study. The Notch ligand Delta has recently been mapped to 6q27, a region of the genome associated with cardiac disease in patients deleted for this region. We will determine if Delta is responsible for a subset of cardiac disease, of the type seen in patients with 6q deletions. We have recently mapped SMRT, a transcriptional co-repressor which has been shown to function downstream of Notch, to 12q24, close to the previously identified critical region for Noonan syndrome, another dominant disorder associated with cardiac disease (in addition to other anomalies). This gene will be tested as a candidate gene for this (Noonan syndrome) disorder.

Project Start
1999-12-01
Project End
2001-02-28
Budget Start
Budget End
Support Year
36
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Medina-Gomez, Carolina; Kemp, John P; Dimou, Niki L et al. (2017) Bivariate genome-wide association meta-analysis of pediatric musculoskeletal traits reveals pleiotropic effects at the SREBF1/TOM1L2 locus. Nat Commun 8:121
Agopian, A J; Goldmuntz, Elizabeth; Hakonarson, Hakon et al. (2017) Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects. Circ Cardiovasc Genet 10:e001449
Ruan, Alexandra; Tobin, Nicole H; Mulligan, Kathleen et al. (2016) Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021. J Acquir Immune Defic Syndr 72:372-5
Medoff-Cooper, Barbara; Irving, Sharon Y; Hanlon, Alexandra L et al. (2016) The Association among Feeding Mode, Growth, and Developmental Outcomes in Infants with Complex Congenital Heart Disease at 6 and 12 Months of Age. J Pediatr 169:154-9.e1
Ollberding, Nicholas J; Gilsanz, Vicente; Lappe, Joan M et al. (2015) Reproducibility and intermethod reliability of a calcium food frequency questionnaire for use in Hispanic, non-Hispanic Black, and non-Hispanic White youth. J Acad Nutr Diet 115:519-27.e2
Medina-Gómez, Carolina; Chesi, Alessandra; Heppe, Denise H M et al. (2015) BMD Loci Contribute to Ethnic and Developmental Differences in Skeletal Fragility across Populations: Assessment of Evolutionary Selection Pressures. Mol Biol Evol 32:2961-72
Avitabile, Catherine M; Goldberg, David J; Zemel, Babette S et al. (2015) Deficits in bone density and structure in children and young adults following Fontan palliation. Bone 77:12-6
Rutstein, Richard M; Samson, Pearl; Fenton, Terry et al. (2015) Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A. Pediatr Infect Dis J 34:162-7
Trabulsi, Jillian C; Irving, S Y; Papas, M A et al. (2015) Total Energy Expenditure of Infants with Congenital Heart Disease Who Have Undergone Surgical Intervention. Pediatr Cardiol 36:1670-9
Lappe, Joan M; Watson, Patrice; Gilsanz, Vicente et al. (2015) The longitudinal effects of physical activity and dietary calcium on bone mass accrual across stages of pubertal development. J Bone Miner Res 30:156-64

Showing the most recent 10 out of 455 publications